<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title40.html">
                                    Title 40
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/40CFR158.html">Part 158
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 158.2050  Biochemical pesticides human health assessment data
                            </h3>
                            <p class="depth1"><em>(a)</em> General. </p><p class="depth2"><em>(1)</em> Sections 158.100 through 158.130 describe how to  use this table to determine the biochemical human health assessment data  requirements for a particular biochemical pesticide product.</p><p class="depth2"><em>(2)</em> The data in this section are not required for straight chain  lepidopteran pheromones when applied up to a maximum use rate of 150  grams active ingredient/acre/year.</p><p class="depth1"><em>(b)</em> Use patterns. </p><p class="depth2"><em>(1)</em> Food use patterns, in general, include  products classified under the following general uses: terrestrial food  crop use; terrestrial feed crop use; aquatic food crop use; greenhouse  food crop use.</p><p class="depth2"><em>(2)</em> Nonfood use patterns include products classified under the  general use patterns of terrestrial nonfood crop use; aquatic nonfood  residential use; aquatic nonfood outdoor use; aquatic nonfood industrial  use; greenhouse nonfood crop use; forestry use; residential outdoor use;  residential indoor use; indoor food use; indoor nonfood use; indoor  medical use.</p><p class="depth1"><em>(c)</em> Key. R=Required; CR=Conditionally required; NR=Not required;  MP=Manufacturing-use product; EP=End-use product; TEP=Typical end-use  product; TGAI=Technical grade of the active ingredient; Residue of  concern=the active ingredient and its metabolites, degradates, and  impurities of toxicological concern; All=All of the above. Specific  conditions, qualifications, or exceptions to the designated test  procedures appear in paragraph (e) of this section, and apply to the  individual tests in the following table:</p><p class="depth1"><em>(d)</em> Table. The following table shows the data requirements for  biochemical pesticides human health assessment. The test notes are shown  in paragraph (e) of this section.</p><p class="depth2">Table--Biochemical Pesticides Human Health Assessment Data Requirements --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">Use Patterns                           Test Substance</p><p class="depth2">Guideline Number           Data Requirement  --------------------------------------------------------------------------------     Test Notes</p><p class="depth2">Food               Nonfood               MP                  EP -------------------------------------------------------------------------------------------------------------------------------------------------------- Tier I --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">Acute Testing -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.1100                          Acute oral          R                   R                   TGAI and MP         TGAI and EP         1</p><p class="depth2">toxicity - rat -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.1200                          Acute dermal        R                   R                   TGAI and MP         TGAI and EP         1, 2</p><p class="depth2">toxicity -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.1300                          Acute inhalation    R                   R                   TGAI and MP         TGAI and EP         3</p><p class="depth2">toxicity - rat -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.2400                          Primary eye         R                   R                   TGAI and MP         TGAI and EP         2</p><p class="depth2">irritation -</p><p class="depth2">rabbit -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.2500                          Primary dermal      R                   R                   TGAI and MP         TGAI and EP         1, 2</p><p class="depth2">irritation -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.2600                          Dermal              R                   R                   TGAI and MP         TGAI and EP         2, 4</p><p class="depth2">sensitization -------------------------------------------------------------------------------------------------------------------------------------------------------- none                              Hypersensitivity    R                   R                   All                 All                 5</p><p class="depth2">incidents --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">Subchronic Testing -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.3100                          90-day oral (one    R                   CR                  TGAI                TGAI                6</p><p class="depth2">species) --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">870.3250                          90-day dermal -     CR                  CR                  TGAI                TGAI                7</p><p class="depth2">rat -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.3465                          90-day inhalation - CR                  CR                  TGAI                TGAI                8</p><p class="depth2">rat --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">Developmental Toxicity -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.3700                          Prenatal            R                   CR                  TGAI                TGAI                9</p><p class="depth2">developmental -</p><p class="depth2">rat preferably --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">Mutagenicity Testing -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.5100                          Bacterial reverse   R                   CR                  TGAI                TGAI                10</p><p class="depth2">mutation test -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.5300                          In vitro mammalian  R                   CR                  TGAI                TGAI                10, 11 870.5375........................   cell assay -------------------------------------------------------------------------------------------------------------------------------------------------------- Tier II --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">Mutagenicity Testing (In vivo cytogenetics) -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.5385                          In vivo Mammalian   CR                  CR                  TGAI                TGAI                13 870.5895........................   Cytogenetics --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">Developmental Toxicity -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.3700                          Prenatal            CR                  CR                  TGAI                TGAI                9</p><p class="depth2">developmental --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">Special Tests -------------------------------------------------------------------------------------------------------------------------------------------------------- 880.3550                          Immunotoxicity      CR                  CR                  TGAI                TGAI                12, 13 --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">Applicator/User Exposure -------------------------------------------------------------------------------------------------------------------------------------------------------- 875.1100                          Dermal outdoor      CR                  CR                  TGAI                TGAI                15</p><p class="depth2">exposure -------------------------------------------------------------------------------------------------------------------------------------------------------- 875.1200                          Dermal indoor       CR                  CR                  TGAI                TGAI                15</p><p class="depth2">exposure -------------------------------------------------------------------------------------------------------------------------------------------------------- 875.1300                          Inhalation outdoor  CR                  CR                  TGAI                TGAI                15</p><p class="depth2">exposure -------------------------------------------------------------------------------------------------------------------------------------------------------- 875.1400                          Inhalation indoor   CR                  CR                  TGAI                TGAI                15</p><p class="depth2">exposure -------------------------------------------------------------------------------------------------------------------------------------------------------- 875.1500                          Biological          CR                  CR                  TGAI                TGAI                15</p><p class="depth2">monitoring -------------------------------------------------------------------------------------------------------------------------------------------------------- Tier III --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">Chronic Testing/Special Testing -------------------------------------------------------------------------------------------------------------------------------------------------------- 880.3800                          Immune response     CR                  CR                  TGAI                TGAI                14 -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.3800                          Reproduction and    CR                  CR                  TGAI                TGAI                16</p><p class="depth2">fertility effects -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.4100                          Chronic oral -      CR                  CR                  TGAI                TGAI                17</p><p class="depth2">rodent and</p><p class="depth2">nonrodent -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.4200                          Carcinogenicity -   CR                  CR                  TGAI                TGAI                18</p><p class="depth2">two species - rat</p><p class="depth2">and mouse</p><p class="depth2">preferred -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.5380                          Mammalian           CR                  CR                  TGAI                TGAI                19</p><p class="depth2">spermatogonial</p><p class="depth2">chromosome</p><p class="depth2">aberration test --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth2">Special Testing -------------------------------------------------------------------------------------------------------------------------------------------------------- 870.7200                          Companion animal    CR                  CR                  NR                  TGAI or EP          20</p><p class="depth2">safety --------------------------------------------------------------------------------------------------------------------------------------------------------</p><p class="depth1"><em>(e)</em> Test notes. The following test notes are applicable to the data  requirements for biochemical pesticides human health assessment as  referenced in the last column of the table in paragraph (d) of this  section.</p><p class="depth2">1. Required unless the test material is a gas or highly volatile  (vapor pressure 10-4torr (mm/Hg)).</p><p class="depth2">2. Required unless the test material is corrosive to skin or has pH  <2 or 11.5.</p><p class="depth2">3. Required when the pesticide, under conditions of use, would  result in respirable material (e.g., gas, volatile substance or aerosol/ particulate), unless it is a straight chain lepidopteran pheromone.</p><p class="depth2">4. Required if repeated contact with human skin is likely to occur  under conditions of use.</p><p class="depth2">5. Hypersensitivity incidents must be reported as adverse effects  data.</p><p class="depth2">6. Required for non-food uses that are likely to result in repeated  oral exposure to humans.</p><p class="depth2">7. Required to support uses involving purposeful application to the  human skin or which would result in comparable prolonged human exposure  to the product (e.g., insect repellents) and if any of the following  criteria are met:</p><p class="depth2">i. Data from a 90-day oral study are not required.</p><p class="depth2">ii. The active ingredient is known or expected to be metabolized  differently by the dermal route of exposure than by the oral route and  the metabolite is of toxicological concern.</p><p class="depth2">iii. The use pattern is such that the dermal route would be the  primary route of exposure.</p><p class="depth2">8. Required if there is a likelihood of significant levels of  repeated inhalation exposure to the pesticide as a gas, vapor, or  aerosol.</p><p class="depth2">9. Required if the use of the product under widespread and commonly  recognized practice may reasonably be expected to result in significant  exposure to female humans (e.g., occupational exposure or repeated  application of insect repellents directly to the skin). Tier II data is  required on a different test species from Tier I data when developmental  effects are observed in the first study and information on species-to- species extrapolation is needed.</p><p class="depth2">10. Required to support nonfood uses if either:</p><p class="depth2">i. The use is likely to result in significant human exposure; or</p><p class="depth2">ii. The active ingredient (or its metabolites) is structurally  related to a known mutagen or belongs to any chemical class of compounds  containing a known mutagen. Additional mutagenicity tests that may have  been performed plus a complete reference list must also be submitted.  Subsequent testing may be required based on the available evidence.</p><p class="depth2">11. Choice of assay using either:</p><p class="depth2">i. Mouse lymphoma L5178Y cells, thymidine kinase (tk) gene locus,  maximizing assay conditions for small colony expression or detection;</p><p class="depth2">ii. Chinese hamster ovary (CHO) or Chinese hamster lung fibroblast  (V79) cells, hypoxanthine-guanine phosphoribosyl transferase (hgprt)  gene locus, accompanied by an appropriate in vitro test for  clastogenicity; or</p><p class="depth2">iii. CHO cells strains AS52, xanthine-guanine phosphoribosyl  transferase (xprt) gene locus.</p><p class="depth2">12. Required if there are effects on hematology, clinical chemistry,  lymphoid organ weights, and histopathology are observed in the 90-day  studies.</p><p class="depth2">13. The micronucleus rodent bone marrow assay is preferred; however,  rodent bone marrow assays using metaphase analysis (aberrations) are  acceptable.</p><p class="depth2">14. Required if adverse effects are observed in the Tier II  immunotoxicity study. The protocol for evaluating adverse effects to the  immune response should be developed after evaluating the effects noted  in the immunotoxicity study.</p><p class="depth2">15. These data are required when the data used for the human health  assessment indicates that the biochemical may pose a potential hazard to  the applicator/user.</p><p class="depth2">16. Required if there is evidence of:</p><p class="depth2">i. Endocrinological effects from the subchronic toxicity studies.</p><p class="depth2">ii. Developmental effects in the prenatal developmental toxicity  study(s), or</p><p class="depth2">iii. Genotoxicity to mammals based on results from the mutagenicity  tests. The use of a combined study that utilizes the two-generation  reproduction study in rodents (guideline 870.3800) as a basic protocol  for the addition of other endpoints or functional assessments in the  immature animal is encouraged.</p><p class="depth2">17. Required if the potential for adverse chronic effects is  indicated based on any of the following:</p><p class="depth2">i. The subchronic effect level established in the following Tier I  studies: 90-day oral toxicity study, 90-day dermal toxicity study, or  90-day inhalation toxicity study.</p><p class="depth2">ii. The pesticide use pattern (e.g., rate, frequency, and site of  application).</p><p class="depth2">iii. The frequency and level of repeated human exposure that is  expected.</p><p class="depth2">18. Required if the product meets either of the following criteria:</p><p class="depth2">i. The active ingredient (or any of its metabolites, degradation  products, or impurities) produce(s) in Tier I subchronic studies a  morphologic effect (e.g., hyperplasia or metaplasia) in any organ that  potentially could lead to neoplastic change.</p><p class="depth2">ii. Adverse cellular effects suggesting carcinogenic potential are  observed in Tier II immunotoxicity and Tier III immune response study or  in Tier II mammalian mutagenicity assays.</p><p class="depth2">In addition, a 90-day range finding study in both rats and mice is  required to determine the dose levels if carcinogenicity studies are  required. If the mouse carcinogenicity study is not required, the 90-day  mouse subchronic study is likewise not required.</p><p class="depth2">19. Required if results from lower tiered mutation or reproductive  studies indicate there is potential for chromosomal aberration to occur.</p><p class="depth2">20. May be required if the product's use will result in exposure to  domestic animals through, but not limited to, direct application or  consumption of treated feed.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
